Coronado Biosciences Forms New Subsidiary, DiaVax Biosciences, to Develop Novel Immunotherapies for Cytomegalovirus

| April 2, 2015 | 0 Comments

NEW YORK — Coronado Biosciences, Inc., has formed a new subsidiary company, DiaVax Biosciences, to develop novel immunotherapies for the prevention and treatment of cytomegalovirus (CMV), a common virus …

Taken from:
Coronado Biosciences Forms New Subsidiary, DiaVax Biosciences, to Develop Novel Immunotherapies for Cytomegalovirus

Tags: , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply